$0
Vice President
2022
Vice President at Scleroderma Clinical Trials Consortium Inc.
Fiscal year ended December 31, 2022. Published on January 25, 2026.
Total compensation
Shervin Assassi, M.D. has been listed as an employee of Scleroderma Clinical Trials Consortium Inc. in Form 990 filings since at least fiscal year 2016.